These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 20503448)

  • 1. Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet.
    Chiba M; Abe T; Tsuda H; Sugawara T; Tsuda S; Tozawa H; Fujiwara K; Imai H
    World J Gastroenterol; 2010 May; 16(20):2484-95. PubMed ID: 20503448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.
    Ford AC; Kane SV; Khan KJ; Achkar JP; Talley NJ; Marshall JK; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):617-29. PubMed ID: 21407190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Hanauer S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis.
    Ford AC; Khan KJ; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2011 Mar; 106(3):413-20. PubMed ID: 20717106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse-Free Course in Nearly Half of Crohn's Disease Patients With Infliximab and Plant-Based Diet as First-Line Therapy: A Single-Group Trial.
    Chiba M; Tsuji T; Nakane K; Tsuda S; Ohno H; Sugawara K; Komatsu M; Tozawa H
    Perm J; 2022 Jun; 26(2):40-53. PubMed ID: 35933676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
    Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
    Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of oral 5-aminosalicylic acid for the prevention of early relapse in Crohn's disease.
    de Franchis R; Omodei P; Ranzi T; Brignola C; Rocca R; Prada A; Pera A; Vecchi M; Del Piano M; Ferrara A; Belloli C; Piodi L; Framarin L; Astegiano M; Riccioli FA; Meucci G
    Aliment Pharmacol Ther; 1997 Oct; 11(5):845-52. PubMed ID: 9354191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS; Zlatanic J; Korelitz BI; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
    Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic Severity Predicts Long-Term Prognosis in Crohn's Disease Patients with Clinical Remission.
    Naganuma M; Hisamatsu T; Matsuoka K; Kiyohara H; Arai M; Sugimoto S; Mori K; Nanki K; Ohno K; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hosoe N; Inoue N; Iwao Y; Ogata H; Kanai T
    Digestion; 2016; 93(1):66-71. PubMed ID: 26789838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: maintenance treatment of Crohn's disease.
    Biancone L; Tosti C; Fina D; Fantini M; De Nigris F; Geremia A; Pallone F
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():31-7. PubMed ID: 12786610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn's Disease Flares.
    Albenberg L; Brensinger CM; Wu Q; Gilroy E; Kappelman MD; Sandler RS; Lewis JD
    Gastroenterology; 2019 Jul; 157(1):128-136.e5. PubMed ID: 30872105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial.
    Yoshida K; Fukunaga K; Ikeuchi H; Kamikozuru K; Hida N; Ohda Y; Yokoyama Y; Iimuro M; Takeda N; Kato K; Kikuyama R; Nagase K; Hori K; Nakamura S; Miwa H; Matsumoto T
    Inflamm Bowel Dis; 2012 Sep; 18(9):1617-23. PubMed ID: 22081474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation.
    Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Romanko I; Bina V; Malickova K; Kolar M; Lukas M
    Scand J Gastroenterol; 2016; 51(2):196-202. PubMed ID: 26329773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment for prevention of relapse and recurrence in Crohn's disease.
    Prantera C; Scribano ML
    Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease.
    Annovazzi A; Biancone L; Caviglia R; Chianelli M; Capriotti G; Mather SJ; Caprilli R; Pallone F; Scopinaro F; Signore A
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):374-82. PubMed ID: 12634965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease.
    Hanai H; Iida T; Takeuchi K; Arai H; Arai O; Abe J; Tanaka T; Maruyama Y; Ikeya K; Sugimoto K; Nakamura T; Nakamura K; Watanabe F
    Dig Liver Dis; 2012 Aug; 44(8):649-54. PubMed ID: 22542605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
    Sutherland LR; Martin F; Bailey RJ; Fedorak RN; Poleski M; Dallaire C; Rossman R; Saibil F; Lariviere L
    Gastroenterology; 1997 Apr; 112(4):1069-77. PubMed ID: 9097988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease.
    Akobeng AK; Gardener E
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003715. PubMed ID: 15674913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis.
    Coward S; Kuenzig ME; Hazlewood G; Clement F; McBrien K; Holmes R; Panaccione R; Ghosh S; Seow CH; Rezaie A; Kaplan GG
    Inflamm Bowel Dis; 2017 Mar; 23(3):461-472. PubMed ID: 28146003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.